Clinical importance of carbapenem hypersensitivity in patients with self-reported and documented penicillin allergy

Pharmacotherapy

Volumn 27, Issue 1, 2007, Pages 137-141

  Prescott Jr , William A ^a   Kusmierski, Kristen A ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

Allergy; Carbapenem; Hypersensitivity; Imipenem cilastatin; Meropenem; Penicillin

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CILASTATIN; CILASTATIN PLUS IMIPENEM; CORTICOSTEROID; ERTAPENEM; MEROPENEM; PENICILLIN DERIVATIVE; PREDNISONE;

ACUTE KIDNEY FAILURE; ANAPHYLAXIS; ANTIBIOTIC THERAPY; ARTHRALGIA; BONE MARROW TRANSPLANTATION; CROSS REACTION; DRUG FEVER; DRUG HYPERSENSITIVITY; FACE EDEMA; HUMAN; INFECTION; INFORMED CONSENT; INTRACUTANEOUS TEST; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL RECORD; NEUTROPENIA; PENICILLIN ALLERGY; PRURITUS; RASH; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; SELF REPORT; SHORT SURVEY; SINGLE DRUG DOSE; WHEEZING;

EID: 33846046021     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.1.137     Document Type: Short Survey

References (17)

1. Leviton I. Separating fact from fiction: the data behind allergies and side effects caused by penicillins, cephalosporins, and carbapenem antibiotics. Curr Pharm Des 2003;9:983-8.
2. Kishiyama JL, Adelman DC. The cross-reactivity and immunology of β-lactam antibiotics. Drug Safety 1994;10:318-27.
3. Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to β-lactam antibiotics. Ann Intern Med 1987;107:204-15.
4. Merck & Co. Primaxin (imipenem-cilastatin) package insert. Whitehouse Station, NJ; 2005.
5. AstraZeneca Pharmaceuticals. Merrem (meropenem) package insert. Wilmington, DE; 2005.
6. Merck & Co. Invanz (ertapenem) package insert. Whitehouse Station, NJ; 2005.
7. Calandra GB, Wang C, Aziz M, Brown KR. The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients. J Antimicrob Chemother 1986;18(suppl E): 193-202.
8. Calandra GB, Ricci FM, Wang C, Brown KR. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials. J Clin Pharmacol 1988;28:120-7.
9. Wang C, Calandra GB, Aziz MA, Brown KR. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience. Rev Infect Dis 1985;7(suppl 3):S528-36.
10. Saxon A, Adelman DC, Patel A, Hajdu R, Calandra GB. Imipenem cross-reactivity with penicillin In humans. J Allergy Clin Immunol 1988;82:213-17.
11. McConnell SA, Penzak SR, Warmack TS, Anaissie EJ, Gubbins PO. Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy. Clin Infect Dis 2000;31:1512-14.
12. Prescott WA, DePestel DD, Ellis JJ, Regal RE. Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy. Clin Infect Dis 2004;38:1102-7.
13. Sodhi M, Axtell SS, Callahan J, Shekar R. Is it safe to use carbapenems in patients with a history of allergy to penicillin? J Antimicrob Chemother 2004;54:1155-7.
14. Salkind AR, Cuddy PG, Foxworth JW. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA 2001;285:2498-505.
15. Kerr JR. Penicillin allergy: a study of incidence as reported by patients. Br J Clin Pract 1994;48:5-7.
16. Absy M, Glatt AE. Antibiotic allergy: inaccurate history taking in a teaching hospital. South Med J 1994;87:805-7.
17. Lee CE, Zembower TR, Fotis MA, et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med 2000;160:2819-22.